Journal of Hematology & Oncology

official impact factor 2.93
Search for
Advanced search
Journal of Hematology & Oncology
Tools
Share this article
Open Access Email this article to a friend

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer

John J Kavanagh, Charles F Levenback, Pedro T Ramirez, Judith L Wolf, Carla L Moore, Marsha R Jones, Lisa Meng, Gail L Brown* and Robert C Bast

Journal of Hematology & Oncology 2010, 3:9 doi:10.1186/1756-8722-3-9

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.